Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH - Euronext Paris - Matif - FR0000060303 - REIT - Currency: EUR

21  -0.1 (-0.47%)

Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 43 industry peers in the Diversified REITs industry. COVH has only an average score on both its financial health and profitability. COVH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COVH had positive earnings in the past year.
COVH had a positive operating cash flow in the past year.
In multiple years COVH reported negative net income over the last 5 years.
COVH had a positive operating cash flow in 4 of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH has a Return On Assets of 0.83%. This is comparable to the rest of the industry: COVH outperforms 44.19% of its industry peers.
COVH has a Return On Equity (1.79%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.94%, COVH is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
Industry RankSector Rank
ROA 0.83%
ROE 1.79%
ROIC 3.94%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 21.69%, COVH is in line with its industry, outperforming 55.81% of the companies in the same industry.
In the last couple of years the Profit Margin of COVH has declined.
COVH's Operating Margin of 105.18% is amongst the best of the industry. COVH outperforms 97.67% of its industry peers.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
With a Gross Margin value of 18.95%, COVH is not doing good in the industry: 79.07% of the companies in the same industry are doing better.
COVH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 105.18%
PM (TTM) 21.69%
GM 18.95%
OM growth 3Y10.96%
OM growth 5Y0.03%
PM growth 3Y43.56%
PM growth 5Y-10.61%
GM growth 3Y-31.65%
GM growth 5Y-15.63%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
COVH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.96, we must say that COVH is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 0.96, COVH is doing good in the industry, outperforming 60.47% of the companies in the same industry.
COVH has a debt to FCF ratio of 11.52. This is a negative value and a sign of low solvency as COVH would need 11.52 years to pay back of all of its debts.
The Debt to FCF ratio of COVH (11.52) is better than 65.12% of its industry peers.
COVH has a Debt/Equity ratio of 0.83. This is a neutral value indicating COVH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.83, COVH perfoms like the industry average, outperforming 41.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 11.52
Altman-Z 0.96
ROIC/WACC0.76
WACC5.18%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.55 indicates that COVH should not have too much problems paying its short term obligations.
The Current ratio of COVH (1.55) is better than 83.72% of its industry peers.
A Quick Ratio of 1.54 indicates that COVH should not have too much problems paying its short term obligations.
The Quick ratio of COVH (1.54) is better than 88.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2047.76%, which is quite impressive.
Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.13% on average per year.
Looking at the last year, COVH shows a small growth in Revenue. The Revenue has grown by 3.03% in the last year.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.28% on average per year.
EPS 1Y (TTM)2047.76%
EPS 3Y62.13%
EPS 5Y-12.13%
EPS Q2Q%224.87%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y14.78%
Revenue growth 5Y2.28%
Sales Q2Q%1.96%

3.2 Future

Based on estimates for the next years, COVH will show a small growth in Earnings Per Share. The EPS will grow by 0.90% on average per year.
Based on estimates for the next years, COVH will show a small growth in Revenue. The Revenue will grow by 0.55% on average per year.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.82, the valuation of COVH can be described as correct.
Based on the Price/Earnings ratio, COVH is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
COVH is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.04, COVH is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH is on the same level as its industry peers.
COVH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 13.82
Fwd PE 12.04
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COVH's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as COVH.
Industry RankSector Rank
P/FCF 11.12
EV/EBITDA 17.43
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.59
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 7.11%, which is a nice return.
Compared to an average industry Dividend Yield of 8.60, COVH pays a bit more dividend than its industry peers.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

The dividend of COVH decreases each year by -4.62%.
Dividend Growth(5Y)-4.62%
Div Incr Years3
Div Non Decr Years3
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

COVH pays out 322.82% of its income as dividend. This is not a sustainable payout ratio.
DP322.82%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (3/7/2025, 7:00:00 PM)

21

-0.1 (-0.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18
Earnings (Next)04-16 2025-04-16
Inst Owners32.4%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.11B
Analysts82.86
Price Target18.67 (-11.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly Dividend1.25
Dividend Growth(5Y)-4.62%
DP322.82%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.82
Fwd PE 12.04
P/S 11.31
P/FCF 11.12
P/OCF 9.7
P/B 0.94
P/tB 0.97
EV/EBITDA 17.43
EPS(TTM)1.52
EY7.24%
EPS(NY)1.74
Fwd EY8.31%
FCF(TTM)1.89
FCFY8.99%
OCF(TTM)2.17
OCFY10.31%
SpS1.86
BVpS22.44
TBVpS21.65
PEG (NY)4.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 1.79%
ROCE 4.45%
ROIC 3.94%
ROICexc 4.25%
ROICexgc 4.34%
OM 105.18%
PM (TTM) 21.69%
GM 18.95%
FCFM 101.71%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.96%
OM growth 5Y0.03%
PM growth 3Y43.56%
PM growth 5Y-10.61%
GM growth 3Y-31.65%
GM growth 5Y-15.63%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 11.52
Debt/EBITDA 8.16
Cap/Depr 87.14%
Cap/Sales 14.91%
Interest Coverage 3.57
Cash Conversion 95.36%
Profit Quality 469.02%
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 0.96
F-Score5
WACC5.18%
ROIC/WACC0.76
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2047.76%
EPS 3Y62.13%
EPS 5Y-12.13%
EPS Q2Q%224.87%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.03%
Revenue growth 3Y14.78%
Revenue growth 5Y2.28%
Sales Q2Q%1.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.74%
EBIT growth 3Y27.37%
EBIT growth 5Y2.3%
EBIT Next Year-17.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.2%
OCF growth 3YN/A
OCF growth 5YN/A